99% Savings - Buy Just @1 Rs X
Codep 37 is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Schizophrenia.
The right dosage of Codep 37 depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Codep 37 side effects, there are can be others also. These have been listed below. These side effects of Codep 37 are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Codep 37's effect during pregnancy is Moderate and Moderate while nursing. In addition, Codep 37's effects on the liver, heart and kidney are discussed below in the Codep 37 related warnings section.
Codep 37 is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease are examples of such conditions. Other conditions have been mentioned below in the Codep 37 contraindications section.
Additionally, Codep 37 may also adversely react with other medicines. See below for a complete list.
You should also be aware that Codep 37 is not safe while driving, and is not addiction.
Codep 37 is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Codep 37 safe for pregnant women?
Codep 37 can have harmful effects in pregnant women. If you experience any discomfort after using Codep 37, then discontinue the use and take your doctor's advice.
Is the use of Codep 37 safe during breastfeeding?
Codep 37 may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Codep 37, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Codep 37.
What is the effect of Codep 37 on the Kidneys?
Codep 37 may have mild side effects on the kidneys.
What is the effect of Codep 37 on the Liver?
Codep 37 is rarely harmful for the liver.
What is the effect of Codep 37 on the Heart?
Information about safety of Codep 37 for heart is not available since scientific research on this is yet to be done.
Codep 37 should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Codep 37 unless your doctor advises you to do so -
Is this Codep 37 habit forming or addictive?
Yes, Codep 37 cause dependence in some cases. Talk to your doctor before taking it.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Codep 37 can make you feel drowsy.
Is it safe?
Yes, Codep 37 is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, in many cases, taking Codep 37 can help with mental disorders.
Interaction between Food and Codep 37
There isn't any research available on the side effects of taking Codep 37 with food.
Interaction between Alcohol and Codep 37
Taking alcohol with Codep 37 can be dangerous.
No, Codep 37 does not cause weight gain. It has not been reported by the patients who are taking this drug. If you are experiencing unusual weight gain after taking this drug then it might be due to some other reason and you are advised to discuss it with your doctor.
Codep 37 is a brand name of chlordiazepoxide and it is available in the form of a tablet. It belongs to the class of drug known as benzodiazepines (sedative and hypnotic). It is a prescription drug which is mainly used in the management of anxiety disorders. Codep 37 is also used to control agitation caused by alcohol withdrawal.
Yes, Codep 37 can make you sleepy because it crosses the blood-brain barrier (a membrane that prevents the drugs from entering into the brain). After entering into the brain this drug calms the brain by increasing the activity of inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that results in drowsiness. It is the most common side effect of this medicine. Activities such as driving and operating heavy machinery should be avoided after taking this Codep 37 to prevent accidents and injuries as it causes drowsiness.
Yes, Codep 37 can be taken with ibuprofen. No harmful drug interaction has been reported between them. It is safe to take Codep 37 along with ibuprofen if it does not exceed recommended doses.
Yes, Codep 37 causes withdrawal symptoms when the drug is suddenly discontinued after long-term treatment. These withdrawal symptoms can include seizures, dysphoria (unease or dissatisfaction), vomiting, sweating, uncontrollable shaking of a part of your body, stomach or muscle cramps, anxiety, or difficulty falling asleep or staying asleep.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Librium® C-IV (chlordiazepoxide HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 401-403
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 433
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trihexyphenidyl Hydrochloride (trihexyphenidyl hydrochloride)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Artane (trihexyphenidyl hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 439-440
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 679-680
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 455-458
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tofranil-PM™ (imipramine pamoate)